Evidence map›Paper›PMID 39659623›Full record

ArticleFrontiers in medicine2024

Realizing real-time optical molecular imaging in peripheral nerve tissue via Rhodamine B.

Jinzheng Wei, Xinyu Guo, Yixi Wang, Yunmeng Zhang, Wei Zhao, Shufeng Han, Chao Liu, Xiaofeng Yang, Wenkai Liang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jinzheng Wei *Department of Orthopaedics, First Hospital of Shanxi Medical University, Taiyuan, China.
Xinyu Guo *Biomedical Engineering Research Center, Shanxi Medical University, Taiyuan, China.
Yixi Wang *School of Electronic Engineering, Xidian University, Xi'an, China.
Yunmeng ZhangBiomedical Engineering Research Center, Shanxi Medical University, Taiyuan, China.
Wei ZhaoDepartment of Orthopaedics, First Hospital of Shanxi Medical University, Taiyuan, China.
Shufeng HanDepartment of Orthopaedics, First Hospital of Shanxi Medical University, Taiyuan, China.
Chao LiuBiomedical Engineering Research Center, Shanxi Medical University, Taiyuan, China.
Xiaofeng YangBiomedical Engineering Research Center, Shanxi Medical University, Taiyuan, China.
Wenkai LiangDepartment of Orthopaedics, First Hospital of Shanxi Medical University, Taiyuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Iatrogenic nerve injury is a consequential complication during surgery. Thus, real-time imaging of peripheral nerve (PN) possesses significant clinical implications. In recent years, the rapid advancements in optical molecular imaging (OMI) technology have provided essential technical foundations for the implementation of PN fluorescence imaging. This study aimed to realize real-time OMI of PNs via Rhodamine B. Methods: Phosphate buffered saline (PBS), normal saline (NS), 5% glucose solution (GS), and fetal bovine serum (FBS) were selected for measuring the fluorescence spectra of Rhodamine B solutions prepared in each formulation. Rhodamine B solutions, with varying doses dissolved in 100 μL of each formulation, were prepared and applied to the exposed PNs of the mice for incubation later. To ascertain the optimal formulation and dose of Rhodamine B, an analysis was performed on the signal-to-background ratio (SBR) of the nerves. Based on the experimental results, we proceeded to incubate Rhodamine B solution on the PN tissue of mice and human subjects, as well as on neuronal cells, to verify the binding sites of Rhodamine B with nerve. Subsequently, histological studies were conducted to validate the binding site between Rhodamine B and the nerves. Finally, we injected the optimal combination of Rhodamine B solution into mice via the tail vein and collected the SBR of mouse nerve tissues at different time intervals to determine the optimal pre-injection time. Fluorescence images of various tissues were collected, and Hematoxylin and Eosin (H&E) staining results were observed to determine the metabolism of Rhodamine B in mice and its toxicity. Results: The excitation peak of Rhodamine B in PBS, NS, 5% GS, and FBS formulations was 554 nm, and the emission peak was 576 nm. In PBS group, the maximum SBR was 15.37 ± 0.68 while the dose of Rhodamine B was 8 nmol. Through Conclusion: Rhodamine B enables fluorescence imaging of PNs and has the potential for clinical translation.

Indexed as

OMI technologyperipheral nervereal-time fluorescence imagingRhodamine BSBR

Identifiers

PMID39659623
PMCPMC11628308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.